TW · Healthcare

SCI Pharmtech Inc (4119)

Drug Manufacturers - Specialty & Generic

SCI Pharmtech Inc (4119) is listed on TW in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 4119

P/E ratio

18.00

SCI Pharmtech Inc (4119) — FAQ

What is 4119's P/E ratio?

The price-to-earnings (P/E) ratio for SCI Pharmtech Inc (4119) is 18.00 (data as of 2026-05-23).

Does SCI Pharmtech Inc pay a dividend?

Dividend yield is not available in the current snapshot for SCI Pharmtech Inc (4119). Check the MyAverix Finance app for the latest dividend data.

What sector is SCI Pharmtech Inc in?

SCI Pharmtech Inc (4119) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is 4119 listed on?

4119 is listed on TW.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)